Teva Pharmaceutical Industries Limited

TEVA· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$34.45-1.61%

2026-08-03

Financials

Valuation Metrics

Teva Pharmaceutical Industries Limited's Market Cap is $40.11B. At end of 2025 it was $35.86B. Ranked #372 of 3,111 in US market (top 12%), #268 of 1,666 on NYSE (top 16%), #19 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 7%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$40.11B	US#372/3,111 Sec#19/269
Revenue	$17.31B	US#371/3,111 Sec#16/269
Net Income	$706M	US#664/3,111 Sec#26/269
Total Assets	$39.86B	US#390/3,111 Sec#17/269
Net Assets	$7.76B	US#517/3,111 Sec#21/269
Value
P/E	56.81x	US#1,920/3,111 Sec#62/269
P/B	5.17x	US#2,234/3,111 Sec#143/269
P/S	2.32x	US#1,455/3,111 Sec#40/269
EV/EBITDA	17.71x	US#1,748/3,111 Sec#52/269
FCF Yield	4.14%	US#1,514/3,111 Sec#53/269
Profitability
ROE	9.10%	US#1,472/3,111 Sec#59/269
ROA	1.77%	US#1,683/3,111 Sec#71/269
Op. Margin	11.45%	US#1,516/3,111 Sec#63/269
Revenue Growth	-0.81%	US#2,307/3,111 Sec#129/269
Earnings Growth	-304.26%	US#2,276/3,111 Sec#87/269
Financial Health
Debt Ratio	413.77%	US#2,315/3,111 Sec#232/269
Total Debt	$16.87B	US#265/3,111 Sec#16/269
FCF	$1.66B	US#397/3,111 Sec#21/269
Cash	$3.65B	US#257/3,111 Sec#16/269
Current Ratio	0.88x	US#2,416/3,111 Sec#267/269
Net Debt/EBITDA	4.39x	US#1,934/3,111 Sec#78/269
Performance
1Y Return	123.96%	US#199/3,111 Sec#60/269
1M Return	-0.56%	US#922/3,111 Sec#59/269
From 52W High	-7.78%	US#638/3,111 Sec#29/269
1Y MDD	-21.79%	US#820/3,111 Sec#41/269
Trading
Volume	4,334,755 shares	US#478/3,111 Sec#32/269
Trading Value	$149M	US#722/3,111 Sec#38/269
Per Share
EPS	$1.23	US#1,537/3,111 Sec#54/269
BPS	$6.88	US#2,057/3,111 Sec#106/269